Loading...
Loading...
All product recalls associated with Breckenridge Pharmaceutical, Inc..
Total Recalls
1000
Past Year
1000
Class I (Serious)
34
Most Recent
Jan 2026
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Listeria monocytogenes. During routine testing the firm received positive test results for Listeria monocytogenes.
Product label includes the ingredient CREAM but does not include Milk as the source.